Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Quantitative Characterization of the Prostatic Urethra Using MRI: Implications for Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia
  2. Sanford, Thomas H; Harmon,Stephanie; Kesani, Deepak; Gurram, Sandeep; Gupta, Nikhil; Mehralivand, Sherif; Sackett, Jonathan; Wiener, Scott; Wood, Bradford J; Xu, Sheng; Pinto, Peter A; Choyke, Peter L; Turkbey, Baris
  3. Academic radiology. 2021, May; 28(5): 664-670.
  1. 2.   A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
  2. Trabbic,Kevin; Whalen, Kaitlyn; Abarca-Heideman, Karin; Xia, Li; Temme,Sebastian; Edmondson,Elijah; Gildersleeve,Jeffrey; Barchi,Joe
  3. Scientific reports. 2019, Apr 5; 9(1):
  1. 3.   Urinary Estrogen Metabolites and Prostate Cancer Risk: A Pilot Study
  2. Kosti, O.; Xu, X.; Veenstra, T. D.; Hsing, A. W.; Chu, L. W.; Goldman, L.; Bebu, I.; Collins, S.; Dritschilo, A.; Lynch, J. H.; Goldman, R.
  3. Prostate. 2011, Apr; 71(5): 507-516.
  1. 4.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 5.   Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
  2. Brouwers, F. M.; Petricoin, E. F.; Ksinantova, L.; Breza, J.; Rajapakse, V.; Ross, S.; Johann, D.; Mannelli, M.; Shulkin, B. L.; Kvetnansky, R.; Eisenhofer, G.; Walther, M. M.; Hitt, B. A.; Conrads, T. P.; Veenstra, T. D.; Mannion, D. P.; Wall, M. R.; Wolfe, G. M.; Fusaro, V. A.; Liotta, L. A.; Pacak, K.
  3. Endocrine-Related Cancer. 2005, JUN; 12(2): 263-272.
  1. 6.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 7.   Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP)
  2. Berman, D. M.; Shih, L. M.; Burke, L. A.; Veenstra, T. D.; Zhao, Y. M.; Conrads, T. P.; Kwon, S. W.; Hoang, V.; Yu, L. R.; Zhou, M.; Kurman, R. J.; Petricoin, E. F.; Liotta, L. A.
  3. Proteomics. 2004 4(3): 812-818.
  1. 8.   Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions
  2. Troyer, J. L.; Pecon-Slattery, J.; Roelke, M. E.; Black, L.; Packer, C.; O'Brien, S. J.
  3. Journal of Virology. 2004 78(7): 3777-3791.
  1. 9.   Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium
  2. Nikitin, A. Y.; Alcaraz, A.; Anver, M. R.; Bonson, R. T.; Cardiff, R. D.; Dixon, D.; Fraire, A. E.; Gabrielson, E. W.; Gunning, W. T.; Haines, D. C.; Kaufman, M. H.; Linnoila, R. I.; Maronpot, R. R.; Rabson, A. S.; Reddick, R. L.; Rehm, S.; Rozengurt, N.; Schuller, H. M.; Shmidt, E. N.; Travis, W. D.; Ward, J. M.; Jacks, T.
  3. Cancer Research. 2004 64(7): 2307-2316.
  1. 10.   Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
  2. Shappell, S. B.; Thomas, G. V.; Roberts, R. L.; Herbert, R.; Ittmann, M. M.; Rubin, M. A.; Humphrey, P. A.; Sundberg, J. P.; Rozengurt, N.; Barrios, R.; Ward, J. M.; Cardiff, R. D.
  3. Cancer Research. 2004 64(6): 2270-2305.
  1. 11.   SELDI-TOF MS for diagnostic proteomics
  2. Issaq, H. J.; Conrads, T. P.; Prieto, D. A.; Tirumalai, R.; Veenstra, T. D.
  3. Analytical Chemistry. 2003 75(7): 148A-155A.
  1. 12.   Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT
  2. Wang, M.; Liu, A.; Garcia, F. U.; Rhim, J. S.; Stearns, M. E.
  3. International Journal of Oncology. 1999 14(6): 1185-1195.
  1. 13.   Expression of Kai1 in Paraffin-Embedded Normal, Hyperplastic and Neoplastic Prostate and Prostate Carcinoma Cell Lines
  2. Ward, J. M.; Konishi, N.; Ohshima, M.; Lamb, P. W.; Jorcyk, C. L.; Barrett, J. C.
  3. Pathology International. 1998 48(2): 87-92.
  1. 14.   Effect of Oncogene Expression On Telomerase Activation and Telomere Length in Human Endothelial, Fibroblast and Prostate Epithelial Cells
  2. Burger, A. M.; Fiebig, H. H.; Kuettel, M. R.; Lautenberger, J. A.; Kung, H. F.; Rhim, J. S.
  3. International Journal of Oncology. 1998 13(5): 1043-1048.
  1. 15.   Loss of Response to Epidermal Growth Factor and Retinoic Acid Accompanies the Transformation of Human Prostatic Epithelial Cells to Tumorigenicity With V-Ki-Ras
  2. Peehl, D. M.; Wong, S. T.; Sellers, R. G.; Jin, S.; Rhim, J. S.
  3. Carcinogenesis. 1997 18(8): 1643-1650.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel